News • Magnetic resonance imaging

Multicolor MRIs could aid disease detection

Researchers at Case Western Reserve University School of Medicine have developed a method that could make magnetic resonance imaging—MRI—multicolor.

Pixabay/toubibe (Montage: healthcare-in-europe.com)

Current MRI techniques rely on a single contrast agent injected into a patient’s veins to vivify images. The new method uses two at once, which could allow doctors to map multiple characteristics of a patient’s internal organs in a single MRI. The strategy could serve as a research tool and even aid disease diagnosis.

“The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents,” said Chris Flask, PhD, Associate Professor of Radiology, Biomedical Engineering, and Pediatrics, and Director of the Imaging Resource Core at Case Western Reserve University School of Medicine. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example. The new method would enable immediate comparisons of how each agent distributes in the same patient.

This multi-agent detection capability has the potential to transform molecular imaging

Chris Flask

“This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients,” said Flask. It also provides a unique imaging platform to rigorously study molecular therapies.” Therapies could include those targeting biomarkers or other detectable molecules associated with diseases.

Flask and colleagues recently described their new method in Nature Scientific Reports. The paper describes how two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs. The authors span 11 departments at Case Western Reserve, uniting engineers, nurses, clinicians, and basic science researchers. They also include several members of the Case Comprehensive Cancer Center. According to the authors, their results provide “an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications.”

The researchers have begun to investigate widespread practical applications for the new MRI approach. Said Flask, “In this initial paper, we validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes.”


Source: Case Western Reserve University

17.08.2017

Read all latest stories

Related articles

Photo

News • CMR-ECV vs. light-chain cardiac amyloidosis

'Stiff heart syndrome': Advanced MRI benefits patients

An advanced form of cardiac MRI has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition ‘stiff heart syndrome’.

Photo

News • In the heart

4D flow MRI scans to assess blood flow

Researchers have developed cutting-edge imaging technology to help doctors better diagnose and monitor patients with heart failure. The state-of-the-art technology uses magnetic resonance imaging…

Photo

News • Targeted treatment

Lung-imaging shows cause of long COVID symptoms

Using functional MRI with inhaled xenon gas, researchers have identified that long COVID symptoms are related to microscopic abnormalities that affect how oxygen is exchanged from the lungs to the…

Related products

allMRI GmbH – Foldable MRI wheelchair

Accessories / Complementary systems

allMRI GmbH – Foldable MRI wheelchair

allMRI GmbH
allMRI GmbH – MRI Safe Handheld Metal Detector

Accessories / Complementary Systems

allMRI GmbH – MRI Safe Handheld Metal Detector

allMRI GmbH
allMRI GmbH – MRI Waste Bin 2x 45 Liter

Accessories / Complementary Systems

allMRI GmbH – MRI Waste Bin 2x 45 Liter

allMRI GmbH
allMRI GmbH – One-way Head Rest Covers for MRI Breast Coils

Accessories / Complementary Systems

allMRI GmbH – One-way Head Rest Covers for MRI Breast Coils

allMRI GmbH
Canon – Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon – Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Subscribe to Newsletter